Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review

Detalhes bibliográficos
Autor(a) principal: Sette, Luís Henrique Bezerra Cavalcanti
Data de Publicação: 2014
Outros Autores: de Almeida Lopes, Edmundo Pessoa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/79416
Resumo: We reviewed the literature regarding the serum levels of the enzymes aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyl transferase in patients with chronic kidney disease on hemodialysis with and without viral hepatitis. Original articles published up to January 2013 on adult patients with chronic kidney disease on hemodialysis were selected. These articles contained the words “transaminases” “aspartate aminotransferase” “alanine aminotransferase” “gamma glutamyl transferase,” “liver enzymes”, AND “dialysis” OR “hemodialysis”. A total of 823 articles were retrieved. After applying the inclusion and exclusion criteria, 49 articles were selected. The patients with chronic kidney disease on hemodialysis had reduced serum levels of aminotransferases due to hemodilution, lower pyridoxine levels, or elevated homocysteine levels. The chronic kidney disease patients on hemodialysis infected with the hepatitis C virus also had lower aminotransferase levels compared with the infected patients without chronic kidney disease. This reduction is in part due to decreased viremia caused by the dialysis method, the production of a hepatocyte growth factor and endogenous interferon-α, and lymphocyte activation, which decreases viral action on hepatocytes. Few studies were retrieved on gamma-glutamyl transferase serum levels; those found reported that there were no differences between the patients with or without chronic kidney disease. The serum aminotransferase levels were lower in the patients with chronic kidney disease on hemodialysis (with or without viral hepatitis) than in the patients with normal renal function; this reduction has a multifactorial origin.
id USP-19_d96ab8a363f9b3e5218513a3683b715c
oai_identifier_str oai:revistas.usp.br:article/79416
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review We reviewed the literature regarding the serum levels of the enzymes aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyl transferase in patients with chronic kidney disease on hemodialysis with and without viral hepatitis. Original articles published up to January 2013 on adult patients with chronic kidney disease on hemodialysis were selected. These articles contained the words “transaminases” “aspartate aminotransferase” “alanine aminotransferase” “gamma glutamyl transferase,” “liver enzymes”, AND “dialysis” OR “hemodialysis”. A total of 823 articles were retrieved. After applying the inclusion and exclusion criteria, 49 articles were selected. The patients with chronic kidney disease on hemodialysis had reduced serum levels of aminotransferases due to hemodilution, lower pyridoxine levels, or elevated homocysteine levels. The chronic kidney disease patients on hemodialysis infected with the hepatitis C virus also had lower aminotransferase levels compared with the infected patients without chronic kidney disease. This reduction is in part due to decreased viremia caused by the dialysis method, the production of a hepatocyte growth factor and endogenous interferon-α, and lymphocyte activation, which decreases viral action on hepatocytes. Few studies were retrieved on gamma-glutamyl transferase serum levels; those found reported that there were no differences between the patients with or without chronic kidney disease. The serum aminotransferase levels were lower in the patients with chronic kidney disease on hemodialysis (with or without viral hepatitis) than in the patients with normal renal function; this reduction has a multifactorial origin. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2014-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/7941610.6061/clinics/2014(04)09Clinics; Vol. 69 No. 4 (2014); 271-278Clinics; v. 69 n. 4 (2014); 271-278Clinics; Vol. 69 Núm. 4 (2014); 271-2781980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/79416/83471Sette, Luís Henrique Bezerra Cavalcanti de Almeida Lopes, Edmundo Pessoa info:eu-repo/semantics/openAccess2014-04-11T19:29:03Zoai:revistas.usp.br:article/79416Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2014-04-11T19:29:03Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review
title Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review
spellingShingle Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review
Sette, Luís Henrique Bezerra Cavalcanti
title_short Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review
title_full Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review
title_fullStr Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review
title_full_unstemmed Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review
title_sort Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review
author Sette, Luís Henrique Bezerra Cavalcanti
author_facet Sette, Luís Henrique Bezerra Cavalcanti
de Almeida Lopes, Edmundo Pessoa
author_role author
author2 de Almeida Lopes, Edmundo Pessoa
author2_role author
dc.contributor.author.fl_str_mv Sette, Luís Henrique Bezerra Cavalcanti
de Almeida Lopes, Edmundo Pessoa
description We reviewed the literature regarding the serum levels of the enzymes aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyl transferase in patients with chronic kidney disease on hemodialysis with and without viral hepatitis. Original articles published up to January 2013 on adult patients with chronic kidney disease on hemodialysis were selected. These articles contained the words “transaminases” “aspartate aminotransferase” “alanine aminotransferase” “gamma glutamyl transferase,” “liver enzymes”, AND “dialysis” OR “hemodialysis”. A total of 823 articles were retrieved. After applying the inclusion and exclusion criteria, 49 articles were selected. The patients with chronic kidney disease on hemodialysis had reduced serum levels of aminotransferases due to hemodilution, lower pyridoxine levels, or elevated homocysteine levels. The chronic kidney disease patients on hemodialysis infected with the hepatitis C virus also had lower aminotransferase levels compared with the infected patients without chronic kidney disease. This reduction is in part due to decreased viremia caused by the dialysis method, the production of a hepatocyte growth factor and endogenous interferon-α, and lymphocyte activation, which decreases viral action on hepatocytes. Few studies were retrieved on gamma-glutamyl transferase serum levels; those found reported that there were no differences between the patients with or without chronic kidney disease. The serum aminotransferase levels were lower in the patients with chronic kidney disease on hemodialysis (with or without viral hepatitis) than in the patients with normal renal function; this reduction has a multifactorial origin.
publishDate 2014
dc.date.none.fl_str_mv 2014-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/79416
10.6061/clinics/2014(04)09
url https://www.revistas.usp.br/clinics/article/view/79416
identifier_str_mv 10.6061/clinics/2014(04)09
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/79416/83471
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 69 No. 4 (2014); 271-278
Clinics; v. 69 n. 4 (2014); 271-278
Clinics; Vol. 69 Núm. 4 (2014); 271-278
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222761171288064